Concepedia

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age

Gustavo H. Dayan, Joan Bevilacqua, Dorothy Coleman, Aileen Buldo, George Risi

Vaccine · 2012 · 58 citations · 38 references

DOI

Concepts

References

38

The Outbreak of West Nile Virus Infection in the New York City Area in 1999

Denis Nash, Farzad Mostashari, Annie D. Fine et al. · New England Journal of Medicine · 2001 · 1.4K citations · Full text

, , +15

Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines

Joseph D. Miller, Robbert van der Most, Rama Akondy et al. · Immunity · 2008 · 613 citations · Full text

, , +16

West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

Brent S. Davis, Gwong‐Jen J. Chang, Bruce C. Cropp et al. · Journal of Virology · 2001 · 447 citations

, , +17

A live, attenuated recombinant West Nile virus vaccine

Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan et al. · Proceedings of the National Academy of Sciences · 2006 · 227 citations · Full text

, , +17

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

Thomas P. Monath, Farshad Guirakhoo, Richard Nichols et al. · The Journal of Infectious Diseases · 2003 · 216 citations

, , +17